These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 7846955)

  • 1. [Hepatocellular carcinoma: molecular biology aspects].
    Blum HE
    Zentralbl Chir; 1994; 119(11):759-63. PubMed ID: 7846955
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Molecular genetic and epigenetic mechanisms of hepatocarcinogenesis].
    Xue KX
    Ai Zheng; 2005 Jun; 24(6):757-68. PubMed ID: 15946497
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular cytogenetic evaluation of virus-associated and non-viral hepatocellular carcinoma: analysis of 26 carcinomas and 12 concurrent dysplasias.
    Zondervan PE; Wink J; Alers JC; IJzermans JN; Schalm SW; de Man RA; van Dekken H
    J Pathol; 2000 Oct; 192(2):207-15. PubMed ID: 11004697
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The pathogenesis of hepatocellular carcinoma is multifactorial event. Novel immunological treatment in prospect.
    Marotta F; Vangieri B; Cecere A; Gattoni A
    Clin Ter; 2004 May; 155(5):187-99. PubMed ID: 15344567
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatocarcinogenesis: hepatitis viruses and altered tumor suppressor gene function.
    Tabor E
    Princess Takamatsu Symp; 1995; 25():151-61. PubMed ID: 8875620
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular therapy and prevention of hepatocellular carcinoma.
    Blum HE
    Hepatobiliary Pancreat Dis Int; 2003 Feb; 2(1):11-22. PubMed ID: 14599923
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pathogenesis of hepatocellular carcinoma: a review from the viewpoint of molecular analysis.
    Kasai Y; Takeda S; Takagi H
    Semin Surg Oncol; 1996; 12(3):155-9. PubMed ID: 8727603
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Molecular aspects of hepatocellular carcinoma].
    Moradpour D; Blum HE
    Zentralbl Chir; 2000; 125(7):592-6. PubMed ID: 10960967
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic evaluation of the dysplasia-carcinoma sequence in chronic viral liver disease: a detailed analysis of two cases and a review of the literature.
    van Dekken H; Wink J; Alers JC; de Man RA; IJzermans JN; Zondervan PE
    Acta Histochem; 2003; 105(1):29-41. PubMed ID: 12666986
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Histocompatibility antigens in patients with hepatocellular carcinoma.
    Golubovic G; Stajic M; Stolic I; Nikolic JA; Neskovic AN; Pandey L
    Z Gastroenterol; 1996 Jan; 34(1):15-20. PubMed ID: 8776170
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New epidemiological data on liver oncogenesis.
    Kountouras J; Lygidakis NJ
    Hepatogastroenterology; 2000; 47(33):855-61. PubMed ID: 10919047
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of pathways associated with hepatitis B- and C-infected hepatocellular carcinoma using pathway-based class discrimination method.
    Lee SY; Song KH; Koo I; Lee KH; Suh KS; Kim BY
    Genomics; 2012 Jun; 99(6):347-54. PubMed ID: 22564472
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular mechanisms of liver carcinogenesis in the mdr2-knockout mice.
    Katzenellenbogen M; Mizrahi L; Pappo O; Klopstock N; Olam D; Jacob-Hirsch J; Amariglio N; Rechavi G; Domany E; Galun E; Goldenberg D
    Mol Cancer Res; 2007 Nov; 5(11):1159-70. PubMed ID: 18025261
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Specific gene-expression profiles of noncancerous liver tissue predict the risk for multicentric occurrence of hepatocellular carcinoma in hepatitis C virus-positive patients.
    Okamoto M; Utsunomiya T; Wakiyama S; Hashimoto M; Fukuzawa K; Ezaki T; Hanai T; Inoue H; Mori M
    Ann Surg Oncol; 2006 Jul; 13(7):947-54. PubMed ID: 16788756
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Survivin (BIRC5) cell cycle computational network in human no-tumor hepatitis/cirrhosis and hepatocellular carcinoma transformation.
    Wang L; Huang J; Jiang M; Sun L
    J Cell Biochem; 2011 May; 112(5):1286-94. PubMed ID: 21312234
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular mechanisms in hepatocellular carcinoma development.
    Cha C; Dematteo RP
    Best Pract Res Clin Gastroenterol; 2005 Feb; 19(1):25-37. PubMed ID: 15757803
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Clonal analysis of regenerating nodules in hepatitis C-induced liver cirrhosis].
    Hensel F; Niederau C
    Z Gastroenterol; 1995 Oct; 33(10):628-9. PubMed ID: 7502561
    [No Abstract]   [Full Text] [Related]  

  • 18. Hepatocellular carcinoma in HCV-infected patients awaiting liver transplantation: genes involved in tumor progression.
    Mas VR; Maluf DG; Stravitz R; Dumur CI; Clark B; Rodgers C; Ferreira-Gonzalez A; Fisher RA
    Liver Transpl; 2004 May; 10(5):607-20. PubMed ID: 15108252
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activation of fetal promoters of insulinlike growth factors II gene in hepatitis C virus-related chronic hepatitis, cirrhosis, and hepatocellular carcinoma.
    Nardone G; Romano M; Calabrò A; Pedone PV; de Sio I; Persico M; Budillon G; Bruni CB; Riccio A; Zarrilli R
    Hepatology; 1996 Jun; 23(6):1304-12. PubMed ID: 8675143
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular targets for therapy of hepatitis B virus-induced hepatocellular carcinoma.
    Tharayil VS; Roberts LR
    Minerva Gastroenterol Dietol; 2006 Dec; 52(4):387-406. PubMed ID: 17108869
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.